Memphis Pharmaceutical & Chemical Industries (MPCI) Financial Statements
Annual financial statement highlights for Memphis Pharmaceutical & Chemical Industries, in Egyptian pounds (EGP) covering fiscal years 2005–2025. Figures are updated weekly from EGX filings via TradingView.
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Total assets | Total debt | DPS |
|---|---|---|---|---|---|---|---|
| 2025 | 1.51B | 505.28M | 22.2101 | 197.98M | 1.49B | 101.6M | 13.187 |
| 2024 | 871.91M | 191.46M | 11.3312 | 213.8M | 1.22B | 177.04M | 4.00 |
| 2023 | 663.83M | 90.44M | 5.3524 | 57.36M | 785.66M | 13.32M | 0.6658 |
| 2022 | 551.26M | 74.09M | 4.3848 | 31.23M | 560.29M | 4.73M | 0.00 |
| 2021 | 518.11M | 41.81M | 2.4742 | 6.09M | 431.58M | 5.36M | 0.00 |
| 2020 | 490.1M | 17.41M | 1.0303 | -1.45M | 377.41M | 0 | 0.00 |
| 2019 | 366.84M | -25.38M | -1.502 | 269,440 | 342.75M | 1.61M | 0.00 |
| 2018 | 343.36M | -46.74M | -2.766 | 20.9M | 375.24M | 37.88M | 0.00 |
| 2017 | 250.21M | -34.22M | -2.0253 | -6.02M | 330.65M | 10.06M | 0.00 |
| 2016 | 357.8M | 88,627 | 0.0052 | 9.43M | 313.61M | 82M | 0.00 |
| 2015 | 396.15M | -10.28M | -0.6081 | -5.03M | 286.69M | 85.27M | 0.00 |
| 2014 | 422.68M | 2.22M | 0.1315 | -4.02M | 246.34M | 25.01M | 0.00 |
| 2013 | 398.22M | 4.62M | 0.2733 | — | 230.01M | 0 | 0.0832 |
| 2012 | 278.99M | 1.04M | — | 6.57M | 229.91M | 0 | 0.0832 |
| 2011 | 350.99M | 5.51M | — | 2.9M | 269.08M | 0 | 0.2497 |
| 2009 | 445.51M | 9.58M | — | 6.79M | 247.76M | 86,859.21 | 0.4261 |
| 2006 | 174.11M | 26.05M | — | 21.32M | 224.43M | 1.79M | 0.4439 |
| 2005 | 163.12M | 22.79M | — | 14.07M | 229.91M | 3.08M | 1.0727 |
All figures in EGP. Source: company disclosures to the Egyptian Exchange via TradingView; updated weekly.